{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["IPTp-Sp", "Malaria", "narrative review, COVID-19", "pregnancy", "prophylaxis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36177658", "DateCompleted": {"Year": "2023", "Month": "06", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1080/20477724.2022.2128563"], "Journal": {"ISSN": "2047-7732", "JournalIssue": {"Volume": "117", "Issue": "5", "PubDate": {"Year": "2023", "Month": "Jul"}}, "Title": "Pathogens and global health", "ISOAbbreviation": "Pathog Glob Health"}, "ArticleTitle": "Intermittent preventive treatment with Sulfadoxine pyrimethamine for malaria: a global overview and challenges affecting optimal drug uptake in pregnant women.", "Pagination": {"StartPage": "462", "EndPage": "475", "MedlinePgn": "462-475"}, "Abstract": {"AbstractText": ["Malaria in Pregnancy (MiP) leading to morbidity and mortality is a major public health problem that poses significant risk to pregnant women and their fetus. To cope with this alarming situation, administration of Sulfadoxine-pyrimethamine (SP) drugs to pregnant women as an intermittent preventive treatment (IPT) from 16\u2009weeks of gestation is recommended by the World Health Organization (WHO) guidelines. We conducted a comprehensive search of published articles related to MiP in last 10\u2009years with predefined keywords or their synonyms. The mapping of malaria in pregnant women showed a prevalence rate up to 35% in many countries. Although IPTp-SP has been implemented in endemic regions since several years but the IPTp-SP coverage percentage vary from country to country and continue to remain below the target of 80%. Major reasons for low IPTp-SP involve gestational age at first prenatal visit, level of education, place of residence, knowledge of IPTp-SP benefits, and use of antenatal services. Several challenges including the emergence of septuple and octuple SP-resistant parasites is reported from many countries which make the prophylactic use of IPTp-SP currently debatable. This narrative review addresses the barriers for optimal use of IPTp-SP and discusses alternative approaches to increase the use and effectiveness of SP intervention for preventing MiP. The COVID pandemic has drastically affected the public health disrupting the management of diseases worldwide. In view of this, a brief summary of COVID impact on MiP situation is also included."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Parasite Host Biology group, ICMR-National Institute of Malaria Research (NIMR), New Delhi, India."}, {"Identifier": [], "Affiliation": "Parasitology laboratory, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}], "LastName": "Nana", "ForeName": "Rodrigue Roman Dongang", "Initials": "RRD"}, {"Identifier": ["0000-0003-4145-9953"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Parasite Host Biology group, ICMR-National Institute of Malaria Research (NIMR), New Delhi, India."}], "LastName": "Hawadak", "ForeName": "Joseph", "Initials": "J"}, {"Identifier": ["0000-0002-4286-147X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Parasite Host Biology group, ICMR-National Institute of Malaria Research (NIMR), New Delhi, India."}], "LastName": "Foko", "ForeName": "Loick Pradel Kojom", "Initials": "LPK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Parasite Host Biology group, ICMR-National Institute of Malaria Research (NIMR), New Delhi, India."}], "LastName": "Kumar", "ForeName": "Amit", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Parasite Host Biology group, ICMR-National Institute of Malaria Research (NIMR), New Delhi, India."}], "LastName": "Chaudhry", "ForeName": "Shewta", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Parasite Host Biology group, ICMR-National Institute of Malaria Research (NIMR), New Delhi, India."}], "LastName": "Arya", "ForeName": "Aditi", "Initials": "A"}, {"Identifier": ["0000-0003-0113-7394"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Parasite Host Biology group, ICMR-National Institute of Malaria Research (NIMR), New Delhi, India."}], "LastName": "Singh", "ForeName": "Vineeta", "Initials": "V"}], "PublicationTypeList": ["Review", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pathog Glob Health", "NlmUniqueID": "101583421", "ISSNLinking": "2047-7724"}, "ChemicalList": [{"RegistryNumber": "37338-39-9", "NameOfSubstance": "fanasil, pyrimethamine drug combination"}, {"RegistryNumber": "Z3614QOX8W", "NameOfSubstance": "Pyrimethamine"}, {"RegistryNumber": "88463U4SM5", "NameOfSubstance": "Sulfadoxine"}, {"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "0", "NameOfSubstance": "Pharmaceutical Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Pyrimethamine"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Sulfadoxine"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antimalarials"}, {"QualifierName": [], "DescriptorName": "Pregnant Women"}, {"QualifierName": [], "DescriptorName": "Pharmaceutical Preparations"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Malaria"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Pregnancy Complications, Parasitic"}], "CoiStatement": "No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "World malaria report 2021, (n.d.) [cited 2021 Dec\n20]. Available from:https://www.who.int/publications-detail-redirect/9789240040496"}, {"Citation": "White NJ, Pukrittayakamee S, Hien TT, et al. Malaria. Lancet. 2014;383(9918):723\u2013735.", "ArticleIdList": ["23953767"]}, {"Citation": "Moore BR, Benjamin JM, Tobe R, et al. A randomized open-label evaluation of the antimalarial prophylactic efficacy of azithromycin-piperaquine versus sulfadoxine-pyrimethamine in pregnant papua new guinean women. Antimicrob Agents Chemother. 2019;63(10). DOI:10.1128/AAC.00302-19", "ArticleIdList": ["10.1128/AAC.00302-19", "PMC6761509", "31405866"]}, {"Citation": "Rogerson SJ, Desai M, Mayor A, et al. Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect Dis. 2018;18(4):e107\u2013e118.", "ArticleIdList": ["29396010"]}, {"Citation": "Pincelli A, Neves PAR, Louren\u00e7o BH, et al.The hidden burden of plasmodium vivax malaria in pregnancy in the amazon: an observational study in northwestern Brazil. Am J Trop Med Hyg. 2018;99(1):73\u201383. DOI:10.4269/ajtmh.18-0135.", "ArticleIdList": ["10.4269/ajtmh.18-0135", "PMC6085809", "29741155"]}, {"Citation": "Hartman TK, Rogerson SJ, Fischer PR.. The impact of maternal malaria on newborns. Ann Trop Paediatr. 2010;30(4):271\u2013282.", "ArticleIdList": ["21118620"]}, {"Citation": "WHO | a strategic framework for malaria prevention and control during pregnancy in the African region (archived), WHO. (n.d.) [cited 2021 Jan\n13]. Available from:http://www.who.int/malaria/publications/atoz/afr_mal_04_01/en/"}, {"Citation": "WHO | Intermittent preventive treatment in pregnancy (IPTp), WHO . (n.d.) [cited 2021 Jan\n13]. Available from:http://www.who.int/malaria/areas/preventive_therapies/pregnancy/en/"}, {"Citation": "WHO | World Malaria Report 2010, WHO . (n.d.)."}, {"Citation": "Ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007;297(23):2603\u20132616.", "ArticleIdList": ["17579229"]}, {"Citation": "Mlugu EM, Minzi O, Asghar M, et al. Effectiveness of sulfadoxine\u2013pyrimethamine for intermittent preventive treatment of malaria and adverse birth outcomes in pregnant women, pathogens. 2020;9:207. DOI:10.3390/pathogens9030207", "ArticleIdList": ["10.3390/pathogens9030207", "PMC7157612", "32168945"]}, {"Citation": "Kayentao K, Garner P, van Eijk AM, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013;309(6):594\u2013604.", "ArticleIdList": ["PMC4669677", "23403684"]}, {"Citation": "Anto F, Agongo IH, Asoala V, et al. Intermittent preventive treatment of malaria in pregnancy: assessment of the sulfadoxine-pyrimethamine three-dose policy on birth outcomes in rural northern Ghana. J Trop Med. 2019;2019:6712685.", "ArticleIdList": ["PMC6582795", "31275401"]}, {"Citation": "Mace KE, Chalwe V, Katalenich BL, et al. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa. Zambia, Malar J. 2015;14. DOI:10.1186/s12936-015-0576-8", "ArticleIdList": ["10.1186/s12936-015-0576-8", "PMC4327785", "25890159"]}, {"Citation": "Nekaka R, Nteziyaremye J, Oboth P, et al. Malaria preventive practices and delivery outcomes: a cross-sectional study of parturient women in a tertiary hospital in Eastern Uganda. PLoS One. 2020;15(8):e0237407.", "ArticleIdList": ["PMC7413511", "32764806"]}, {"Citation": "Mpogoro FJ, Matovelo D, Dosani A, et al. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in geita district, north-western Tanzania. Malar J. 2014;13(1):455.", "ArticleIdList": ["PMC4256934", "25421496"]}, {"Citation": "Pell C, Straus L, Andrew EVW, et al. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS One. 2011;6(7):e22452.", "ArticleIdList": ["PMC3140529", "21799859"]}, {"Citation": "Mchwampaka WM, Tarimo D, Chacky F, et al. Factors affecting uptake of \u2265\u20093 doses of sulfadoxine-pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania. BMC Pregnancy Childbirth. 2019;19(1). DOI:10.1186/s12884-019-2592-0", "ArticleIdList": ["10.1186/s12884-019-2592-0", "PMC6880562", "31775686"]}, {"Citation": "van Eijk AM, Larsen DA, Kayentao K, et al. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19(5):546\u2013556.", "ArticleIdList": ["30922818"]}, {"Citation": "Naidoo I, Roper C. Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria. Trends Parasitol. 2013;29(10):505\u2013515.", "ArticleIdList": ["24028889"]}, {"Citation": "Okell LC, Griffin JT, Roper C. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci Rep. 2017;7(1):7389.", "ArticleIdList": ["PMC5547055", "28785011"]}, {"Citation": "Green BN, Johnson CD, Adams A. Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2006;5(3):101\u2013117.", "ArticleIdList": ["PMC2647067", "19674681"]}, {"Citation": "Desai M, Ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7(2):93\u2013104.", "ArticleIdList": ["17251080"]}, {"Citation": "World malaria report 2020, (n.d.) [cited 2021 Jan\n13]. Available from:https://www.who.int/publications-detail-redirect/9789240015791"}, {"Citation": "Kattenberg JH, Tahita CM, Versteeg IAJ, et al. Evaluation of antigen detection tests, microscopy, and polymerase chain reaction for diagnosis of malaria in peripheral blood in asymptomatic pregnant women in Nanoro, Burkina Faso. Am J Trop Med Hyg. 2012;87(2):251\u2013256.", "ArticleIdList": ["PMC3414559", "22859362"]}, {"Citation": "Matangila JR, Lufuluabo J, Ibalanky AL, et al. Asymptomatic Plasmodium falciparum infection is associated with anaemia in pregnancy and can be more cost-effectively detected by rapid diagnostic test than by microscopy in Kinshasa, democratic republic of the Congo. Malar J. 2014;13(1):132.", "ArticleIdList": ["PMC3976674", "24690179"]}, {"Citation": "Siame MN, Mharakurwa S, Chipeta J, et al. High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia. Malar J. 2015;14(1). DOI:10.1186/s12936-015-0676-5", "ArticleIdList": ["10.1186/s12936-015-0676-5", "PMC4425916", "25943379"]}, {"Citation": "Mbonye AK, Birungi J, Yanow SK, et al. Prevalence of Plasmodium falciparum Resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda. Antimicrob Agents Chemother. 2015;59(9):5475\u20135482.", "ArticleIdList": ["PMC4538518", "26124154"]}, {"Citation": "Boudov\u00e1 S, Divala T, Mawindo P, et al. The prevalence of malaria at first antenatal visit in Blantyre, Malawi declined following a universal bed net campaign. Malar J. 2015;14(1):422.", "ArticleIdList": ["PMC4625940", "26510414"]}, {"Citation": "Chaponda EB, Chandramohan D, Michelo C, et al. High burden of malaria infection in pregnant women in a rural district of Zambia: a cross-sectional study. Malar J. 2015;14(1). DOI:10.1186/s12936-015-0866-1", "ArticleIdList": ["10.1186/s12936-015-0866-1", "PMC4590700", "26423819"]}, {"Citation": "Ma\u00efga-Ascofar\u00e9 O, Rakotozandrindrainy R, Girmann M, et al. Molecular epidemiology and seroprevalence in asymptomatic Plasmodium falciparum infections of Malagasy pregnant women in the highlands. Malar J. 2015;14(1):188.", "ArticleIdList": ["PMC4432997", "25935753"]}, {"Citation": "Williams J, Njie F, Cairns M, et al. Non-Falciparum malaria infections in pregnant women in West Africa. Malar J. 2016;15(1). DOI:10.1186/s12936-016-1092-1", "ArticleIdList": ["10.1186/s12936-016-1092-1", "PMC4731909", "26823277"]}, {"Citation": "Francine N, Damien B, Anna F, et al. Characterization of asymptomatic Plasmodium falciparum infection and its risk factors in pregnant women from the republic of Congo. Acta Trop. 2016;153:111\u2013115.", "ArticleIdList": ["26477849"]}, {"Citation": "Monjol BE, Useh MF. Detection of Plasmodium falciparum chloroquine resistance transporter (PfCRT) mutant gene amongst malaria-infected pregnant women in Calabar, Nigeria. Ann Parasitol. 2017;63(4):323\u2013330.", "ArticleIdList": ["29419995"]}, {"Citation": "Mart\u00ednez-P\u00e9rez G, Lansana DP, Omeonga S, et al. Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, Liberia. Malar J. 2018;17(1):357.", "ArticleIdList": ["PMC6186138", "30314489"]}, {"Citation": "Ojurongbe O, Nguetse CN, Fayemiwo SA, et al. High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine. Pathog Glob Health. 2018;112(2):86\u201392.", "ArticleIdList": ["PMC6056817", "29318942"]}, {"Citation": "Kayiba NK, Yobi DM, Tchakounang VRK, et al. Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in kingasani hospital, kinshasa in the democratic republic of Congo. Infect Genet Evol. 2021;94:105009.", "ArticleIdList": ["34284138"]}, {"Citation": "Doritchamou JYA, Akuffo RA, Moussiliou A, et al. Submicroscopic placental infection by non-falciparum Plasmodium spp. PLoS Negl Trop Dis. 2018;12(2):e0006279.", "ArticleIdList": ["PMC5825172", "29432484"]}, {"Citation": "Anabire NG, Aryee PA, Abdul-Karim A, et al. Prevalence of malaria and hepatitis B among pregnant women in northern Ghana: comparing RDTs with PCR. PLoS One. 2019;14:e0210365.", "ArticleIdList": ["PMC6364880", "30726218"]}, {"Citation": "Mlugu EM, Minzi O, Kamuhabwa AAR, et al. Prevalence and correlates of asymptomatic malaria and anemia on first antenatal care visit among pregnant women in southeast, Tanzania. Int J Environ Res Public Health. 2020;17(9):3123.", "ArticleIdList": ["PMC7246851", "32365839"]}, {"Citation": "Gikunju SW, Agola EL, Ondondo RO, et al. Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at msambweni county referral hospital, Kwale County, Kenya. Malar J. 2020;19(1):190.", "ArticleIdList": ["PMC7247205", "32448228"]}, {"Citation": "McGregor D, Texeira da Silva E, Grignard L, et al. The epidemiology of Plasmodium falciparum malaria in the Bijagos Islands of Guinea-bissau. Am J Trop Med Hyg. 2021;tpmd201029. DOI:10.4269/ajtmh.20-1029", "ArticleIdList": ["10.4269/ajtmh.20-1029", "PMC8176492", "33782209"]}, {"Citation": "Bardaj\u00ed A, Mart\u00ednez-Espinosa FE, Ar\u00e9valo-Herrera M, et al. PregVax study group, burden and impact of Plasmodium vivax in pregnancy: a multi-centre prospective observational study. PLoS Negl Trop Dis. 2017;11(6):e0005606.", "ArticleIdList": ["PMC5481034", "28604825"]}, {"Citation": "V\u00e1squez A-M, Zuluaga-Id\u00e1rraga L, Arboleda M, et al. Malaria in pregnancy in endemic regions of colombia: high frequency of asymptomatic and peri-urban infections in pregnant women with malaria. Infect Dis Obstet Gynecol. 2020;2020:2750258.", "ArticleIdList": ["PMC7455813", "32884230"]}, {"Citation": "V\u00e1squez AM, V\u00e9lez G, Medina A, et al. Evaluation of highly sensitive diagnostic tools for the detection of P. falciparum in pregnant women attending antenatal care visits in Colombia. BMC Pregnancy Childbirth. 2020;20(1):440.", "ArticleIdList": ["PMC7393871", "32736543"]}, {"Citation": "Dombrowski JG, Barateiro A, Peixoto EPM, et al. Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon. PLoS Negl Trop Dis. 2021;15(4):e0009390.", "ArticleIdList": ["PMC8112668", "33914739"]}, {"Citation": "Gavina K, Gnidehou S, Arango E, et al. clinical outcomes of submicroscopic infections and correlates of protection of VAR2CSA antibodies in a longitudinal study of pregnant women in Colombia. Infect Immun. 2018;86:e00797\u201317. DOI:10.1128/IAI.00797-17.", "ArticleIdList": ["10.1128/IAI.00797-17", "PMC5865023", "29378797"]}, {"Citation": "Barber BE, Bird E, Wilkes CS, et al. Plasmodium knowlesi malaria during pregnancy. J Infect Dis. 2015;211(7):1104\u20131110.", "ArticleIdList": ["25301955"]}, {"Citation": "Briand V, Le Hesran J-Y, Mayxay M, et al. Prevalence of malaria in pregnancy in southern Laos: a cross-sectional survey. Malar J. 2016;15(1). DOI:10.1186/s12936-016-1492-2", "ArticleIdList": ["10.1186/s12936-016-1492-2", "PMC5002160", "27566274"]}, {"Citation": "Elbadry MA, Tagliamonte MS, Raccurt CP, et al. Submicroscopic malaria infections in pregnant women from six departments in Haiti. Trop Med Int Health. 2017;22(8):1030\u20131036.", "ArticleIdList": ["28609010"]}, {"Citation": "Khan WA, Galagan SR, Prue CS, et al. Asymptomatic Plasmodium falciparum malaria in pregnant women in the chittagong hill districts of Bangladesh. PLoS One. 2014;9(5):e98442.", "ArticleIdList": ["PMC4032281", "24858193"]}, {"Citation": "Sohail M, Shakeel S, Kumari S, et al. Prevalence of malaria infection and risk factors associated with anaemia among pregnant women in semiurban community of Hazaribag, Jharkhand, India. Biomed Res Int. 2015;2015:740512.", "ArticleIdList": ["PMC4691455", "26783526"]}, {"Citation": "Tan SO, McGready R, Zwang J, et al. Thrombocytopaenia in pregnant women with malaria on the Thai-burmese border. Malar J. 2008;7(1):209.", "ArticleIdList": ["PMC2579302", "18922167"]}, {"Citation": "WHO Guidelines for malaria , (n.d.) [cited 2022 Jul\n15]. Available from:https://www.who.int/publications-detail-redirect/guidelines-for-malaria"}, {"Citation": "Schultz LJ, Steketee RW, Chitsulo L, et al. Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalarial regimens for use in pregnancy: chloroquine and sulfadoxine-pyrimethamine. Am J Trop Med Hyg. 1996;55(1_Suppl):87\u201394.", "ArticleIdList": ["8702045"]}, {"Citation": "Schultz LJ, Steketee RW, Chitsulo L, et al. Antimalarials during pregnancy: a cost-effectiveness analysis. Bull World Health Organ. 1995;73(2):207\u2013214.", "ArticleIdList": ["PMC2486762", "7743592"]}, {"Citation": "Brabin BJ, Verhoeff FH, Kazembe P, et al. Antimalarial drug policy in Malawi. Null. 1997;91:S113\u2013S115."}, {"Citation": "Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg. 1998;59(5):813\u2013822.", "ArticleIdList": ["9840604"]}, {"Citation": "Schultz LJ, Steketee RW, Macheso A, et al. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg. 1994;51(5):515\u2013522.", "ArticleIdList": ["7985742"]}, {"Citation": "Verhoeff FH, Brabin BJ, Chimsuku L, et al. An evaluation of the effects of intermittent sulfadoxine\u2014pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol. 1998;92(2):141\u2013150.", "ArticleIdList": ["9625909"]}, {"Citation": "S. WHO Expert Committee on Malaria (1998 : Geneva, W.H. Organization, WHO Expert Committee on Malaria : twentieth report , World Health Organization; 2000.  [cited 2022 Jul\n14]. Available from:https://apps.who.int/iris/handle/10665/42247"}, {"Citation": "WHO | World Malaria Report 2010, WHO . (n.d.) [cited 2021 Jan\n13]. Available from:https://www.who.int/malaria/publications/atoz/9789241564106/en/"}, {"Citation": "van Eijk AM, Hill J, Larsen DA, et al. Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009\u201311. Lancet Infect Dis. 2013;13(12):1029\u20131042.", "ArticleIdList": ["24054085"]}, {"Citation": "Nabarro D. Roll back malaria. Parassitologia. 1999;41(1\u20133):501\u2013504.", "ArticleIdList": ["10697910"]}, {"Citation": "World malaria\nReport 2012, WHO . (2012) [cited 2020 Oct\n25]. Available from:https://www.who.int/malaria/publications/world_malaria_report_2012/en/"}, {"Citation": "Ahmed R, Poespoprodjo JR, Syafruddin D, et al. Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial. Lancet Infect Dis. 2019;19(9):973\u2013987.", "ArticleIdList": ["PMC6715823", "31353217"]}, {"Citation": "WHO | World Malaria Report 2015, WHO . (n.d.) [cited 2020 Oct\n25]. Available from:http://www.who.int/malaria/publications/world-malaria-report-2015/en/"}, {"Citation": "Pons-Duran C, Llach M, Sacoor C, et al. Coverage of intermittent preventive treatment of malaria in pregnancy in four sub-Saharan countries: findings from household surveys. Int J Epidemiol. 2021;50(2):550\u2013559.", "ArticleIdList": ["PMC8128463", "33349871"]}, {"Citation": "Bertin G, Briand V, Bonaventure D, et al. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin. Malar J. 2011;10(1). 196. DOI:10.1186/1475-2875-10-196.", "ArticleIdList": ["10.1186/1475-2875-10-196", "PMC3199903", "21767415"]}, {"Citation": "Ruizendaal E, Tahita MC, Geskus RB, et al. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro. Burkina Faso, Malar J. 2017;16:179.", "ArticleIdList": ["PMC5410088", "28454537"]}, {"Citation": "Lucchi NW, Okoth SA, Komino F, et al. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum inWestern Kenya. Antimicrob Agents Chemother. 2015;59(7):3995\u20134002.", "ArticleIdList": ["PMC4468674", "25896703"]}, {"Citation": "Guidelines for the treatment of malaria -\nThird edition, (n.d.) [cited 2021 Jan\n14]. Available from:https://www.who.int/publications-detail-redirect/9789241549127"}, {"Citation": "Bauserman M, Conroy AL, North K, et al. An overview of malaria in pregnancy. Semin Perinatol. 2019;43(5):282\u2013290.", "ArticleIdList": ["PMC7895297", "30979598"]}, {"Citation": "D\u2019Alessandro U, Hill J, Tarning J, et al. Treatment of uncomplicated and severe malaria during pregnancy. Lancet Infect Dis. 2018;18(4):e133\u2013e146.", "ArticleIdList": ["PMC6590069", "29395998"]}, {"Citation": "Yimam Y, Nateghpour M, Mohebali M, et al. A systematic review and meta-analysis of asymptomatic malaria infection in pregnant women in Sub-Saharan Africa: a challenge for malaria elimination efforts. PLoS One. 2021;16(4):e0248245.", "ArticleIdList": ["PMC8016273", "33793584"]}, {"Citation": "Fried M, Muehlenbachs A, Duffy PE. Diagnosing malaria in pregnancy: an update, expert review of anti-infective therapy. 2012;10:1177\u20131187. DOI:10.1586/eri.12.98", "ArticleIdList": ["10.1586/eri.12.98", "PMC3552641", "23199403"]}, {"Citation": "Kovacs SD, Rijken MJ, Stergachis A. Treating severe malaria in pregnancy: a review of the evidence. Drug Saf. 2015;38(2):165\u2013181.", "ArticleIdList": ["PMC4328128", "25556421"]}, {"Citation": "Saito M, Gilder ME, McGready R, et al. Antimalarial drugs for treating and preventing malaria in pregnant and lactating women. Expert Opin Drug Saf. 2018;17(11):1129\u20131144.", "ArticleIdList": ["30351243"]}, {"Citation": "D\u2019Alessandro S, Menegola E, Parapini S, et al. Safety of artemisinin derivatives in the first trimester of pregnancy: a controversial story. Molecules. 2020;25(15):3505.", "ArticleIdList": ["PMC7435965", "32752056"]}, {"Citation": "Dellicour S, Sevene E, McGready R, et al. First-Trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies. PLoS Med. 2017;14(5):e1002290.", "ArticleIdList": ["PMC5412992", "28463996"]}, {"Citation": "Augusto O, Stergachis A, Dellicour S, et al. First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age. Malar J. 2020;19(1). DOI:10.1186/s12936-020-03210-y", "ArticleIdList": ["10.1186/s12936-020-03210-y", "PMC7140480", "32268901"]}, {"Citation": "Rouamba T, Sondo P, Derra K, et al. Optimal approach and strategies to strengthen pharmacovigilance in sub-Saharan Africa: a cohort study of patients treated with first-line artemisinin-based combination therapies in the nanoro health and demographic surveillance system, Burkina Faso. Drug Des Devel Ther. 2020;14:1507\u20131521.", "ArticleIdList": ["PMC7174163", "32368010"]}, {"Citation": "World malaria report 2019, (n.d.) [cited 2020 Oct\n25]. Available from:https://www.who.int/publications-detail-redirect/9789241565721"}, {"Citation": "Hill J, D\u2019Mello-Guyett L, Hoyt J, et al. Women\u2019s access and provider practices for the case management of malaria during pregnancy: a systematic review and meta-analysis. PLoS Med. 2014;11(8):e1001688.", "ArticleIdList": ["PMC4122360", "25093720"]}, {"Citation": "Okethwangu D, Opigo J, Atugonza S, et al. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda demographic and Health Survey. Malar J. 2016;18(1):250.", "ArticleIdList": ["PMC6660695", "31349829"]}, {"Citation": "Azizi SC. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015\u20132016. BMC Public Health. 2020;20(1). DOI:10.1186/s12889-020-08471-5", "ArticleIdList": ["10.1186/s12889-020-08471-5", "PMC7077170", "32178658"]}, {"Citation": "Eisele TP, Larsen DA, Anglewicz PA, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012;12(12):942\u2013949.", "ArticleIdList": ["22995852"]}, {"Citation": "Nyaaba GN, Olaleye AO, Obiyan MO, et al. A socio-ecological approach to understanding the factors influencing the uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in south-western Nigeria. PLoS One. 2021;16(3):e0248412.", "ArticleIdList": ["PMC7959387", "33720947"]}, {"Citation": "Mutanyi JA, Onguru DO, Ogolla SO, et al. Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia sub county, western Kenya. Infect Dis Poverty. 2021;10(1):106.", "ArticleIdList": ["PMC8343925", "34362443"]}, {"Citation": "Balami AD, Md Said S, Mohd Zulkefli NA, et al. Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health centre in Maiduguri, Nigeria. BMC Pregnancy Childbirth. 2020;20(1):726.", "ArticleIdList": ["PMC7687802", "33238901"]}, {"Citation": "Wafula ST, Mendoza H, Nalugya A, et al. Determinants of uptake of malaria preventive interventions among pregnant women in eastern Uganda. Malar J. 2021;20(1):5.", "ArticleIdList": ["PMC7780677", "33390153"]}, {"Citation": "Hill J, Hoyt J, van Eijk AM, et al. Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2013;10(7):e1001488.", "ArticleIdList": ["PMC3720261", "23935459"]}, {"Citation": "Dun-Dery F, Meissner P, Beiersmann C, et al. Uptake challenges of intermittent preventive malaria therapy among pregnant women and their health care providers in the upper west region of Ghana: a mixed-methods study. Parasite Epidemiol Control. 2021;15:e00222.", "ArticleIdList": ["PMC8488310", "34632123"]}, {"Citation": "Oppong FB, Gyaase S, Zandoh C, et al. Intermittent preventive treatment of pregnant women in kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015. BMJ Open. 2019;9(6):e027946.", "ArticleIdList": ["PMC6596987", "31230017"]}, {"Citation": "Awantang GN, Babalola SO, Koenker H, et al. Malaria-Related ideational factors and other correlates associated with intermittent preventive treatment among pregnant women in Madagascar. Malar J. 2018;17(1):176.", "ArticleIdList": ["PMC5918989", "29695231"]}, {"Citation": "Olugbade OT, Ilesanmi OS, Gubio AB, et al. Socio-Demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013. Pan Afr Med J. 2019;32:13.", "ArticleIdList": ["PMC6441474", "30949287"]}, {"Citation": "Darteh EKM, Buabeng I, Akuamoah-Boateng C. Uptake of intermittent preventive treatment in pregnancy for malaria: further analysis of the 2016 Ghana malaria indicator survey. J Public Health (Berl). 2020. DOI:10.1007/s10389-020-01206-1", "ArticleIdList": ["10.1007/s10389-020-01206-1"]}, {"Citation": "Exavery A, Mbaruku G, Mbuyita S, et al. Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania. Malar J. 2014;13(1):22.", "ArticleIdList": ["PMC3898402", "24423279"]}, {"Citation": "Sangho O, Tounkara M, Whiting-Collins LJ, et al. Determinants of intermittent preventive treatment with sulfadoxine\u2013pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey. Malar J. 2021;20(1):231.", "ArticleIdList": ["PMC8141251", "34022901"]}, {"Citation": "Ndu A, Mbachu C, Anitube O, et al. Inequities in the use of sulphadoxine-pyrimethamine for malaria prophylaxis during pregnancy in Nigeria. Malawi Med J. 2020;32(1):45\u201351.", "ArticleIdList": ["PMC7366158", "32733659"]}, {"Citation": "Amoran OE, Ariba AA, Iyaniwura CA. Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria, reprod health. 2012;9:12. DOI:10.1186/1742-4755-9-12", "ArticleIdList": ["10.1186/1742-4755-9-12", "PMC3453493", "22889320"]}, {"Citation": "Amankwah S, Anto F. Factors associated with uptake of intermittent preventive treatment of malaria in pregnancy: a cross-sectional study in private health facilities in Tema Metropolis, Ghana. J Trop Med. 2019;2019:9278432.", "ArticleIdList": ["PMC6699305", "31467566"]}, {"Citation": "Ameh S, Owoaje E, Oyo-Ita A, et al. Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in cross river state, Nigeria: a cross-sectional study. BMC Pregnancy Childbirth. 2016;16(1). DOI:10.1186/s12884-016-0883-2", "ArticleIdList": ["10.1186/s12884-016-0883-2", "PMC4857401", "27147109"]}, {"Citation": "Nkunzimana E, Babale MS. Knowledge and utilisation of intermittent preventive treatment of malaria among pregnant women in muramvya health district, Burundi, 2018. East Afr Health Res J. 2020;4(1):81\u201391.", "ArticleIdList": ["PMC8279260", "34308224"]}, {"Citation": "Akpa CO, Akinyemi JO, Umeokonkwo CD, et al. Uptake of intermittent preventive treatment for malaria in pregnancy among women in selected communities of Ebonyi state, Nigeria. BMC Pregnancy Childbirth. 2019;19(1). DOI:10.1186/s12884-019-2629-4", "ArticleIdList": ["10.1186/s12884-019-2629-4", "PMC6888909", "31791271"]}, {"Citation": "Azizi SC, Chongwe G, Chipukuma H, et al. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-pyrimethamine (IPTp-SP) among postpartum women in Zomba district, Malawi: a cross-sectional study. BMC Pregnancy Childbirth. 2018;18(1):108.", "ArticleIdList": ["PMC5910602", "29678150"]}, {"Citation": "Sherrard-Smith E, Hogan AB, Hamlet A, et al. The potential public health consequences of COVID-19 on malaria in Africa. Nat Med. 2020;26(9):1411\u20131416.", "ArticleIdList": ["PMC7613562", "32770167"]}, {"Citation": "De-Gaulle VF, Magnussen P, Kamgno J, et al. Assessing health system factors affecting access and delivery of IPTp-SP and ITN to pregnant women attending ANC clinics in Ghana. BMC Health Serv Res. 2021;21(1):1056.", "ArticleIdList": ["PMC8493749", "34610842"]}, {"Citation": "Bello OO, Oni O. Health workers\u2019 awareness and knowledge of current recommendation of intermittent preventive treatment in pregnancy in south-western Nigeria. Ethiop J Health Sci. 2020;30(1):125\u2013134.", "ArticleIdList": ["PMC7036451", "32116441"]}, {"Citation": "Olaleye AO, Walker O. Impact of health systems on the implementation of intermittent preventive treatment for malaria in pregnancy in sub-Saharan Africa: a narrative synthesis. Trop Med Infect Dis. 2020;5(3):E134.", "ArticleIdList": ["PMC7558380", "32842592"]}, {"Citation": "Aberese-Ako M, Magnussen P, Ampofo GD, et al. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context. PLoS One. 2021;16(10):e0257666.", "ArticleIdList": ["PMC8496863", "34618812"]}, {"Citation": "Dhama K, Khan S, Tiwari R, et al. Coronavirus disease 2019\u2013COVID-19. Clin Microbiol Rev. 2020;33(4). DOI:10.1128/CMR.00028-20", "ArticleIdList": ["10.1128/CMR.00028-20", "PMC7405836", "32580969"]}, {"Citation": "Chiodini J. COVID-19 and the impact on travel health advice. Travel Med Infect Dis. 2020;36:101824.", "ArticleIdList": ["PMC7375963", "32711033"]}, {"Citation": "Quakyi I, Tornyigah B, Houze P, et al. High uptake of intermittent preventive treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana, scientific reports. 2019;9:19034. DOI:10.1038/s41598-019-55046-5", "ArticleIdList": ["10.1038/s41598-019-55046-5", "PMC6911095", "31836735"]}, {"Citation": "Fagbemi KA, Adebusuyi SA, Nderu D, et al. Analysis of sulphadoxine\u2013pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun state, southwest Nigeria, infection. Gene Evolut. 2020;85:104503.", "ArticleIdList": ["32805431"]}, {"Citation": "Ngondi JM, Ishengoma DS, Doctor SM, et al. Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the lake and southern zones, Tanzania, using pooling and next-generation sequencing. Malar J. 2017;16(1):236.", "ArticleIdList": ["PMC5460401", "28583119"]}, {"Citation": "Gutman J, Kalilani L, Taylor S, et al. The A581 G mutation in the gene encoding Plasmodium falciparum dihydropteroate synthetase reduces the effectiveness of sulfadoxine-pyrimethamine preventive therapy in malawian pregnant women. J Infect Dis. 2015;211(12):1997\u20132005.", "ArticleIdList": ["PMC4539907", "25564249"]}, {"Citation": "Saito M, Briand V, Min AM, et al. Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs. Lancet Child Adolesc Health. 2020;4(10):761\u2013774.", "ArticleIdList": ["32946830"]}, {"Citation": "WHO | Co-trimoxazole prophylaxis for malaria and bacterial infections in people with HIV, WHO. (n.d.) [cited 2021 Jan\n14]. Available from:https://www.who.int/hiv/topics/arv/cotrimoxazole_factsheet_dec2014/en/"}, {"Citation": "WHO | Malaria and HIV Interactions and their Implications for Public Health Policy, WHO . (n.d.) [cited 2021 Jan\n14]. https://www.who.int/hiv/pub/prev_care/malaria/en/"}, {"Citation": "Desai M, Hill J, Fernandes S, et al. Prevention of malaria in pregnancy. Lancet Infect Dis. 2018;18(4):e119\u2013e132.", "ArticleIdList": ["29395997"]}, {"Citation": "Graybill LA, Kasaro M, Freeborn K, et al. Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2020;34(5):761\u2013776.", "ArticleIdList": ["PMC7275092", "32167990"]}, {"Citation": "Kajubi R, Ochieng T, Kakuru A, et al. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. Lancet. 2019;393:1428\u20131439.", "ArticleIdList": ["30910321"]}, {"Citation": "Roh ME, Kuile FOT, Rerolle F, et al. Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis. Lancet Glob Health. 2020;8(7):e942\u2013e953.", "ArticleIdList": ["PMC7303957", "32562650"]}, {"Citation": "Olaleye A, Okusanya BO, Oduwole O, et al. A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy. Int J Gynaecol Obstet. 2019;146(1):43\u201355.", "ArticleIdList": ["31050803"]}, {"Citation": "Divala TH, Mungwira RG, Mawindo PM, et al. Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial. Lancet Infect Dis. 2018;18(10):1097\u20131107.", "ArticleIdList": ["PMC6217965", "30195996"]}, {"Citation": "Kimani J, Phiri K, Kamiza S, et al. Efficacy and safety of Azithromycin-chloroquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa: an open-label, randomized trial. PLoS One. 2016;11(6):e0157045.", "ArticleIdList": ["PMC4915657", "27326859"]}, {"Citation": "Akinyotu O, Bello F, Abdus-Salam R, et al. A randomized controlled trial of azithromycin and sulphadoxine\u2013pyrimethamine as prophylaxis against malaria in pregnancy among human immunodeficiency virus\u2013positive women. Trans R Soc Trop Med Hyg. 2019;113(8):463\u2013470.", "ArticleIdList": ["31140565"]}, {"Citation": "Desai M, Gutman J, L\u2019Lanziva A, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet. 2015;386(10012):2507\u20132519.", "ArticleIdList": ["PMC4718402", "26429700"]}, {"Citation": "Esu E, Berens-Riha N, Pritsch M, et al. Intermittent screening and treatment with artemether\u2013lumefantrine versus intermittent preventive treatment with sulfadoxine\u2013pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria. Malar J. 2018;17(1):251.", "ArticleIdList": ["PMC6034215", "29976228"]}, {"Citation": "Teo A, Randall LM, Madanitsa M, et al. Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women. Sci Rep. 2019;9(1):7878.", "ArticleIdList": ["PMC6536723", "31133672"]}, {"Citation": "Tagbor H, Cairns M, Bojang K, et al. A non-inferiority, individually randomized trial of intermittent screening and treatment versus intermittent preventive treatment in the control of malaria in pregnancy. PLoS One. 2015;10(8):e0132247.", "ArticleIdList": ["PMC4530893", "26258474"]}, {"Citation": "Tagbor H, Bruce J, Agbo M, et al. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS One. 2010;5(12):e14425.", "ArticleIdList": ["PMC3010999", "21203389"]}, {"Citation": "Madanitsa M, Kalilani L, Mwapasa V, et al. Scheduled intermittent screening with rapid diagnostic tests and treatment with dihydroartemisinin-piperaquine versus intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy in Malawi: an open-label randomized controlled trial. PLoS Med. 2016;13:e1002124.", "ArticleIdList": ["PMC5021271", "27622558"]}, {"Citation": "Awine T, Belko MM, Oduro AR, et al. The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine. Malar J. 2016;15(1):46.", "ArticleIdList": ["PMC4730594", "26821532"]}, {"Citation": "Gutman JR, Khairallah C, Stepniewska K, et al. Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine- pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials. EClinicalMedicine. 2021;41:101160.", "ArticleIdList": ["PMC8556518", "34746720"]}, {"Citation": "Hill J, Ouma P, Oluoch S, et al. Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya. Malar J. 2020;19(1):433.", "ArticleIdList": ["PMC7690090", "33238999"]}, {"Citation": "Webster J, Ansariadi FHB, Landuwulang CUR, et al. Evaluation of the implementation of single screening and treatment for the control of malaria in pregnancy in Eastern Indonesia: a systems effectiveness analysis. Malar J. 2018;17(1):310.", "ArticleIdList": ["PMC6108152", "30143047"]}, {"Citation": "Kuepfer I, Mishra N, Bruce J, et al. Effectiveness of intermittent screening and treatment for the control of malaria in pregnancy: a cluster randomised trial in India. BMJ Glob Health. 2019;4(4):e001399.", "ArticleIdList": ["PMC6666812", "31406586"]}, {"Citation": "Scott S, D\u2019Alessandro U, Kendall L, et al.Community-based malaria screening and treatment for pregnant women receiving standard intermittent preventive treatment with Sulfadoxine-pyrimethamine: a multicenter (The Gambia, Burkina Faso, and Benin) cluster-randomized controlled trial. Clin Infect Dis. 2019;68(4):586\u2013596. DOI:10.1093/cid/ciy522.", "ArticleIdList": ["10.1093/cid/ciy522", "PMC6355825", "29961848"]}, {"Citation": "Uwimana A, Umulisa N, Venkatesan M, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21(8):1120\u20131128.", "ArticleIdList": ["PMC10202849", "33864801"]}, {"Citation": "Uwimana A, Legrand E, Stokes BH, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26(10):1602\u20131608.", "ArticleIdList": ["PMC7541349", "32747827"]}, {"Citation": "Balikagala B, Fukuda N, Ikeda M, et al. Evidence of Artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385(13):1163\u20131171.", "ArticleIdList": ["34551228"]}, {"Citation": "WHO Malaria Policy Advisory Committee and Secretariat Malaria policy advisory committee to the WHO: conclusions and recommendations of eighth biannual meeting (september 2015. Malar J. 2016;15(1):117. DOI:10.1186/s12936-016-1169-x.", "ArticleIdList": ["10.1186/s12936-016-1169-x", "PMC4766637", "26911803"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "14", "Hour": "6", "Minute": "42"}, {"Year": "2022", "Month": "10", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "30", "Hour": "3", "Minute": "22"}, {"Year": "2023", "Month": "9", "Day": "30"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36177658", "PMC10337642", "10.1080/20477724.2022.2128563"]}}], "PubmedBookArticle": []}